Video Experimental Relacionado
Updated: Sep 9, 2025

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Informe de caso: Bradicardia inducida por fracción de flavonoides purificados micronizados [Daflon]
Jhennyfer Aline Lima Rodrigues1, Jonathas Pereira das Graças1, Gledson de Oliveira Machado2
1Universidade Estadual de Goiás, Goiás, Brazil.
La fracción de flavonoides purificados micronizados (MPFF) redujo significativamente la frecuencia cardíaca en pacientes con trastornos venosos crónicos. Este estudio sugiere que el MPFF puede atenuar la frecuencia cardíaca, potencialmente relacionando sus efectos venoactivos con la regulación cardiovascular.
Área de la Ciencia:
- Farmacología
- Fisiología cardiovascular
Sus antecedentes:
- Los flavonoides, incluidos la diosmina y la hesperidina en el MPFF, se utilizan para los trastornos venosos crónicos.
- MPFF (Daflon 1000 mg) posee propiedades antiinflamatorias y antioxidantes.
Más Videos Relacionados
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Videos de Conceptos Relacionados
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VII: Nursing Management of Dysrhythmias